Relapsing-remitting Multiple Sclerosis (RRMS) Clinical Trials in Ottawa, Ontario
2 recruitingOttawa, Ontario, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen444 enrolled109 locationsNCT06700343
Recruiting
Phase 4
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS
Relapsing-remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals224 enrolled14 locationsNCT06733922